Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Acute Plasmodium falciparum malaria following splenectomy for suspected lymphoma in 2 patients.

Bidegain F, Berry A, Alvarez M, Verhille O, Huguet F, Brousset P, Pris J, Marchou B, Magnaval JF.

Clin Infect Dis. 2005 Jun 1;40(11):e97-100. Epub 2005 Apr 22.

PMID:
15889352
2.

Acute myelogenous leukemia following mitoxantrone treatment for multiple sclerosis.

Mogenet I, Simiand-Erdociain E, Canonge JM, Pris J.

Ann Pharmacother. 2003 May;37(5):747-8. No abstract available. Retraction in: Ann Pharmacother. 2004 Jan;38(1):176-7.

PMID:
12708958
3.

[Superficial adenopathy].

Pris J, Recher C.

Rev Prat. 2002 Feb 15;52(4):417-22. French. No abstract available.

PMID:
11944553
4.

Sweet's syndrome associated with retinoic acid syndrome in a patient with promyelocytic leukemia.

Astudillo L, Loche F, Reynish W, Rigal-Huguet F, Lamant L, Pris J.

Ann Hematol. 2002 Feb;81(2):111-4. Epub 2002 Jan 10.

PMID:
11907794
5.

[Macrocytic anemia in adults. Physiopathology, etiology, diagnosis, and treatment].

Pris J, Khatibi S.

Rev Prat. 2000 Nov 15;50(18):2059-65. French. No abstract available.

PMID:
11192978
6.

Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.

Aurich J, Duchayne E, Huguet-Rigal F, Bauduer F, Navarro M, Perel Y, Pris J, Caballin MR, Dastugue N.

Hematol Cell Ther. 1998 Aug;40(4):149-58.

PMID:
9766919
7.

[Etiological aspects of reactive hemophagocytoses: retrospective study in 99 patients].

Sailler L, Duchayne E, Marchou B, Brousset P, Pris J, Massip P, Corberand J, Arlet P.

Rev Med Interne. 1997;18(11):855-64. Review. French.

PMID:
9499986
8.

Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 study.

Reiffers J, Stoppa AM, Attal M, Michallet M, Marit G, Blaise D, Huguet F, Corront B, Cony-Makhoul P, Gastaut JA, Laurent G, Molina L, Broustet A, Maraninchi D, Pris J, Hollard D, Faberes C.

Leukemia. 1996 Dec;10(12):1874-82.

PMID:
8946925
9.

Bcl-x gene expression in Hodgkin's disease.

Schlaifer D, Krajewski S, Rigal-Huguet F, Laurent G, Pris J, Delsol G, Reed JC, Brousset P.

Leuk Lymphoma. 1996 Sep;23(1-2):143-6.

PMID:
9021697
10.

Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection.

Schlaifer D, Krajewski S, Galoin S, Rigal-Huguet F, Laurent G, Massip P, Pris J, Delsol G, Reed JC, Brousset P.

Am J Pathol. 1996 Jul;149(1):177-85.

11.

Frequent expression of the cell death-inducing gene Bax in Reed-Sternberg cells of Hodgkin's disease.

Brousset P, Benharroch D, Krajewski S, Laurent G, Meggetto F, Rigal-Huguet F, Gopas J, Prinsloo I, Pris J, Delsol G, Reed JC, Schlaifer D.

Blood. 1996 Mar 15;87(6):2470-5.

PMID:
8630413
12.

A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75.

Reiffers J, Huguet F, Stoppa AM, Molina L, Marit G, Attal M, Gastaut JA, Michallet M, Lepeu G, Broustet A, Pris J, Maraninchi D, Hollard D, Fabères C, Mercier M, Hurteloup P, Danel P, Tellier Z, Berthaud P.

Leukemia. 1996 Mar;10(3):389-95.

PMID:
8642852
13.

Vincristine degradation by serum from leukemic patients: role of myeloperoxidase.

Schlaifer D, Duchayne E, Demur C, Alvinerie P, Muller C, Attal M, Cooper MR, Payen C, Monsarrat B, Myers CE, Pris J, Laurent G.

Leuk Lymphoma. 1996 Feb;20(5-6):441-6.

PMID:
8833400
14.

High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease.

Schlaifer D, March M, Krajewski S, Laurent G, Pris J, Delsol G, Reed JC, Brousset P.

Blood. 1995 May 15;85(10):2671-4.

PMID:
7742524
15.

Symptomatic osteonecrosis in recipients of nonautologous bone marrow transplants.

Sixou L, Lassoued S, Attal M, Dromer C, Leguennec P, Ludot I, Laroche M, Pris J, Fournié B.

Rev Rhum Engl Ed. 1995 May;62(5):359-63.

PMID:
7655869
16.

Epstein-Barr virus in familial Hodgkin's disease.

Schlaifer D, Rigal-Huguet F, Robert A, Attal M, Abbal M, Fonck Y, Laurent G, Pris J, Delsol G, Brousset P.

Br J Haematol. 1994 Nov;88(3):636-8.

PMID:
7819081
17.

Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease.

Brousset P, Schlaifer D, Meggetto F, Bachmann E, Rothenberger S, Pris J, Delsol G, Knecht H.

Blood. 1994 Oct 15;84(8):2447-51.

PMID:
7919364
18.

Secondary neoplasms in two patients treated with purine analogues.

Schlaifer D, Riga-Huguet F, Pris J, Brousset P, Delannoy A, Bosly A.

Nouv Rev Fr Hematol. 1994 Aug;36(4):341. No abstract available.

PMID:
7971258
19.

bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma.

Schlaifer D, Brousset P, Attal M, Massip P, Payen C, Marchou B, Huguet F, Muller C, Laurent G, Pris J, et al.

Histopathology. 1994 Jul;25(1):77-82.

PMID:
7959648
20.

B-cell lymphoma following polycythemia vera: evidence for the involvement of two different clones.

Schlaifer D, Dastugue N, Brousset P, Delsol G, Muller C, Rigal-Huguet F, Attal M, Laurent G, Pris J.

Leukemia. 1994 May;8(5):895-6.

PMID:
8182947
21.

Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloids.

Schlaifer D, Cooper MR, Attal M, Rousseau A, Pris J, Laurent G, Myers CE.

Leukemia. 1994 Apr;8(4):668-71.

PMID:
8152263
22.

Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in refractory lymphoma patients undergoing autologous bone marrow transplantation.

Schlaifer D, Attal M, Huguet F, Canal P, Laurent G, Pris J.

Semin Hematol. 1994 Apr;31(2 Suppl 3):31. No abstract available.

PMID:
8073306
23.

Antisense inhibition of myeloperoxidase increases the sensitivity of the HL-60 cell line to vincristine.

Schlaifer D, Meyer K, Muller C, Attal M, Smith MT, Tamaki S, Weimels J, Pris J, Jaffrézou JP, Laurent G, et al.

Leukemia. 1994 Feb;8(2):289-91.

PMID:
7905941
24.

Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.

Attal M, Canal P, Schlaifer D, Chatelut E, Dezeuze A, Huguet F, Payen C, Pris J, Laurent G.

J Clin Oncol. 1994 Jan;12(1):141-8.

PMID:
8270970
25.

De novo acute leukemia with a sole 5q-: morphological, immunological, and clinical correlations.

Duchayne E, Dastugue N, Kuhlein E, Huguet F, Pris J.

Leuk Lymphoma. 1993 Nov;11(5-6):387-92.

PMID:
8124211
26.

Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial.

Attal M, Huguet F, Rubie H, Charlet JP, Schlaifer D, Huynh A, Laurent G, Pris J.

Blood. 1993 Aug 1;82(3):732-6.

PMID:
8338943
27.

Leuconostoc, a potential pathogen in bone marrow transplantation.

Giraud P, Attal M, Lemouzy J, Huguet F, Schlaifer D, Pris J.

Lancet. 1993 Jun 5;341(8858):1481-2. No abstract available.

PMID:
8099181
28.

[Portal thrombosis, hereditary protein C deficiency and Vaquez disease].

Hamidou M, Laurent G, Rigal-Huguet F, Sie P, Pris J.

Ann Med Interne (Paris). 1993;144(1):71-2. French. No abstract available.

PMID:
8503620
29.

[Alveolar opacities and busulfan pneumonia].

About I, Lauque D, Levenes H, Mazerolles C, Pujazon MC, Pris J, Carles P.

Rev Mal Respir. 1993;10(1):39-41. Review. French.

PMID:
8451493
30.

t(9;11)(p22;q23) translocation in blastic phase of chronic myeloid leukemia.

Dastugue N, Duchayne E, Huguet F, Demur C, Plaisancie H, Calvas P, Bourrouillou G, Pris J, Colombies P.

Cancer Genet Cytogenet. 1992 Oct 1;63(1):37-42.

PMID:
1423224
31.

Intensive combined therapy for previously untreated aggressive myeloma.

Attal M, Huguet F, Schlaifer D, Payen C, Laroche M, Fournie B, Mazieres B, Pris J, Laurent G.

Blood. 1992 Mar 1;79(5):1130-6.

PMID:
1536941
32.

Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapy.

Attal M, Huguet F, Schlaifer D, Payen C, Lassoued S, Laroche M, Rossi JF, Fournie B, Mazieres B, Pris J, et al.

Bone Marrow Transplant. 1991 Aug;8(2):125-8.

PMID:
1933053
33.

Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.

Attal M, Schlaifer D, Rubie H, Huguet F, Charlet JP, Bloom E, Lemozy J, Massip P, Pris J, Laurent G.

J Clin Oncol. 1991 May;9(5):865-70.

PMID:
2016630
34.

Consequences of moderate hypoxia on red cell glycolytic metabolism in polycythemia rubra vera.

Arnaud J, Pris J, Brun H, Constans J.

Ann Biol Clin (Paris). 1991;49(1):9-13.

PMID:
2048771
35.

[Magnetic resonance imaging in the bone sites of malignant non-Hodgkin's lymphoma. Apropos of 16 cases].

Assoun J, Poey C, Attal M, Huguet F, De Haldat F, Giron J, Maquin P, Pris J, Railhac JJ.

Ann Radiol (Paris). 1991;34(6-7):383-6, 389-92. French.

PMID:
1822661
36.

Hydroxyurea versus interferon alfa-2b in chronic myelogenous leukaemia: preliminary results of an open French multicentre randomized study.

Broustet A, Reiffers J, Marit G, Fiere D, Jaubert J, Reynaud J, Pris J, Bernard P, Charrin C, Wen ZQ, et al.

Eur J Cancer. 1991;27 Suppl 4:S18-21.

PMID:
1799467
37.

[Moschcowitz syndrome associated with Waldenström's disease].

Schlaifer D, Rigal-Huguet F, Mazerrolles C, Attal M, Pris J.

Presse Med. 1990 Nov 10;19(37):1722. French. No abstract available.

PMID:
2147490
38.

Pharmacokinetics of idarubicin after oral administration in elderly leukemic patients.

Robert J, Rigal-Huguet F, Huet S, Pris J, Hurteloup P.

Leukemia. 1990 Mar;4(3):227-9.

PMID:
2179640
39.

Translocation t(3;21)(q26;q22) in acute myeloblastic leukemia secondary to polycythemia vera.

Dastugue N, Pris J, Colombies P.

Cancer Genet Cytogenet. 1990 Feb;44(2):275-6.

PMID:
2297687
40.

[Chronic lactic acidosis and acute lymphoblastic leukemia].

Schlaifer D, Rigal-Huguet F, Laurent G, Pris J.

Rev Med Interne. 1990 Jan-Feb;11(1):91. French. No abstract available.

PMID:
2326561
41.

[Fulminating hepatitis by type 5 adenoviruses during Hodgkin's disease].

Bouabdallah K, Rigal-Huguet F, Alard C, Laurent G, Gayet-Mengelle C, Pris J, Delsol G.

Ann Med Interne (Paris). 1990;141(1):81-2. French. No abstract available.

PMID:
2321889
42.

[Current data on large cell anaplastic lymphomas co-expressing EMA, Ki-1 antigens and IL2 receptor].

Delsol G, Brousset P, Gaspar MH, Rigal-Huguet F, Mazerolles C, Barillet-Alard C, al Saati T, Laurent G, Pris J.

Pathol Biol (Paris). 1989 Nov;37(9):1060-1. French. No abstract available.

PMID:
2608343
43.

[Chronic relapsing polychondritis. Clinical characteristics].

Arlet P, Pris J, Sallerin F, Vilain C, Laroche M, Le Tallec Y.

Presse Med. 1989 Feb 4;18(4):157-60. French.

PMID:
2522198
44.

Treatment of acute myeloid leukemia in elderly patients with oral idarubicin as a single agent.

Harousseau JL, Rigal-Huguet F, Hurteloup P, Guy H, Milpied N, Pris J.

Eur J Haematol. 1989 Feb;42(2):182-5.

PMID:
2917635
45.

[Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin].

Rubie H, Attal M, Lemozy J, Massip P, Huguet F, Pris J, Robert A, Régnier C.

Pathol Biol (Paris). 1988 Sep;36(7):912-4. French.

PMID:
3059276
46.

[Contribution of immunohistochemical technics to the study of malignant infiltration of bone marrow].

Delsol G, Al Saati T, Faure PH, Caverivière P, Chittal S, Rigal-Huguet F, Robert A, Laurent G, Pris J.

Pathol Biol (Paris). 1988 Jan;36(1):11-6. French.

PMID:
3283666
47.

Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.

Vialaneix JP, Malet-Martino MC, Hoffmann JS, Pris J, Martino R.

Drug Metab Dispos. 1987 Sep-Oct;15(5):718-24.

PMID:
2891491
48.

[Primary biliary cirrhosis associated with autoimmune thrombopenic purpura and pleuropericarditis].

Calès P, Vinel JP, Voigt JJ, de Forni M, Oksman F, Chamontin B, Duffaut M, Pris J, Pascal JP.

Gastroenterol Clin Biol. 1987 Jun-Jul;11(6-7):518. French. No abstract available.

PMID:
3609649
49.

Treatment of 218 adult acute lymphoblastic leukemias.

Fiere D, Extra JM, David B, Witz F, Vernand JP, Gastaut JA, Dauriac C, Pris J, Marty M.

Semin Oncol. 1987 Jun;14(2 Suppl 1):64-6. No abstract available.

PMID:
3296208
50.

Pharmacokinetics of idarubicin after daily intravenous administration in leukemic patients.

Robert J, Rigal-Huguet F, Harousseau JL, Pris J, Huet S, Reiffers J, Hurteloup P, Tamassia V.

Leuk Res. 1987;11(11):961-4.

PMID:
3480399

Supplemental Content

Support Center